Overview of pain and sensitization

Chronic Abdominal and Visceral Pain: Theory and Practice

Volumn , Issue , 2006, Pages 17-32

  Gold, Michael S ^a,b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863927099     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (170)

1. Merskey H, Bogduk N. Classification of Chronic Pain, IASP Press, Seattle, 1994:240.
2. Lee SJ et al. Fetal pain: a systematic multidisciplinary review of the evidence. JAMA 2005; 294: 947-954.
3. Chen JI et al. Differentiating noxious- and innocuous-related activation of human somatosensory cortices using temporal analysis of fMRI. J Neurophysiol 2002; 88:464-474.
4. Coghill RC, McHaffie JG, Yen YF. Neural correlates of interindividual differences in the subjective experience of pain. Proc Natl Acad Sci USA 2003; 100:8538-8542.
5. Moulton EA et al. Regional intensive and temporal patterns of functional MRI activation distinguishing noxious and innocuous contact heat. J Neurophysiol 2005; 93:2183-2193.
6. Rainville P, Bushnell MC, Duncan GH. Representation of acute and persistent pain in the human CNS: potential implications for chemical intolerance. Ann N Y Acad Sci. 2001; 933:130-141.
7. Ribeiro SC et al. Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 2005.
8. Zubieta JK et al. Regional μ opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293:311-315.
9. Rainville P et al. Dissociation of sensory and affective dimensions of pain using hypnotic modulation. Pain 1999; 82:159-171.
10. Ploner M, Freund HJ, Schnitzler A. Pain affect without pain sensation in a patient with a postcentral lesion. Pain 1999; 81:211-214.
11. Head H, Holmes G. Sensory disturbances from cerebral lesions. Brain 1911; 34:102-154.
12. Melzack R, Wall PD. Pain Mechanisms: a new theory. Science 1965; 150:971-979.
13. Caterina MJ, Gold MS, Meyer RA. Molecular biology of nociceptors. In: Hunt S, Koltzenburg M, eds. The Neurobiology of Pain. Oxford: Oxford University Press, 2005:1-33.
14. Sengupta JN, Gebhart GF. Characterization of mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat. J Neurophysiol 1994; 71:2046-2060.
15. Sengupta JN, Kauvar D, Goyal RK Characteristics of vagal esophageal tension-sensitive afferent fibers in the opossum. J Neurophysiol 1989; 61:1001-1010.
16. Bandler R, Shipley MT. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci 1994; 17:379-389.
17. Johnson MH, How does distraction work in the management of pain? Curr Pain Headache Rep 2005; 9:90-95.
18. Lieberman HR et al. Mood, performance, and pain sensitivity: changes induced by food constituents. J Psychiatr Res 1982; 17:135-145.
19. Frye CA, Cuevas CA, Kanarek RB. Diet and estrous cycle influence pain sensitivity in rats. Pharmacol Biochem Behav 1993; 45:255-260.
20. McGivern RF, Berntson GG. Mediation of diurnal fluctuations in pain sensitivity in the rat by food intake patterns: reversal by naloxone. Science 1980; 210:210-211.
21. Gibson SJ, Farrell M. A review of age differences in the neurophysiology of nociception and the perceptual experience of pain. Clin J Pain 2004; 20:227-239.
22. Aley KO et al. Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 2000; 20:4680-4685.
23. Ren K et al. Characterization of basal and re-inflammation-associated long-term alteration in pain responsivity following short-lasting neonatal local inflammatory insult. Pain 2004; 110:588-596.
24. Mendell LM, Wall PD. Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965; 206:97-99.
25. Shavit Y et al. Stress, opioid peptides, the immune system, and cancer. J Immunol 1985; 135:834s-837s.
26. Lewis JW et al. Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B). Nat Immun Cell Growth Regul 1983; 3:43-50.
27. Merskey H et al. Pain terms: a list with definitions and notes on usage. Recommended by the IASP subcommittee on taxonomy. Pain 1979; 6:249-252.
28. Backonja MM. Defining neuropathic pain. Anesth Analg 2003; 97:785-790.
29. Backonja MM, Stacey B. Neuropathic pain symptoms relative to overall pain rating. J Pain 2004; 5:491-497.
30. Koltzenburg M, Lundberg LER, Torebjork HE. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 1992; 51:207-219.
31. Mayer EA, Naliboff B, Munakata J. The evolving neurobiology of gut feelings. Prog Brain Res 2000; 122:195-206.
32. Price DD. Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol Interv 2002; 2:339,392-403.
33. Tominaga M, Caterina MJ. Thermosensation and pain. J Neurobiol 2004; 61:3-12.
34. Gold MS. Molecular basis of receptors. In: Merskey H, Loeser JD, Dubner R, eds. The paths of pain 1975-2005. Seattle: IASP Press, 2005.
35. McCarter GC, Reichling DB, Levine JD, Mechanical transduction by rat dorsal root ganglion neurons in vitro. Neurosci Lett 1999; 273:179-182.
36. Caterina MJ et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389:816-824.
37. McKemy DD, Neuhausser WM, Julius D, Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002; 416:52-58.
38. Peier AM et al. A TRP channel that senses cold stimuli and menthol. Cell 2002; 108:705-715.
39. Chen CC et al. A sensory neuron-specific, proton-gated ion channel. Proc Natl Acad Sci USA 1998; 95:10240-10245.
40. Waldmann R et al. Molecular cloning of a non-inactivating proton-gated Na+ channel specific for sensory neurons. J Biol Chem 1997; 272:20975-20978.
41. Waldmann R et al. A proton-gated cation channel involved in acid-sensing. Nature 1997; 386: 173-177.
42. Page AJ et al. Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function. Gut 2005; 54:1408-1415.
43. Kellenberger S, Schild L. Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev 2002; 82:735-767.
44. Birder LA. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol Renal Physiol 2005; 289:F489-F495.
45. Wynn G et al. Purinergic mechanisms contribute to mechanosensory transduction in the rat color- ectum. Gastroenterology 2003; 125:1398-1409.
46. North RA. P2X3 receptors and peripheral pain mechanisms. J Physiol 2004; 554:301-308.
47. Wynn G et al. Purinergic component of mechanosensory transduction is increased in a rat model of colitis. Am J Physiol Gastrointest Liver Physiol 2004; 287:G647-G657.
48. Dang K et al. Gastric ulcers evoke hyperexcitability and enhance P2X receptor function in rat gastric sensory neurons. J Neurophysiol 2005; 93:3112-3119.
49. Xu GY, Huang LY. Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons. J Neurosci 2002; 22:93-102.
50. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7:309-338.
51. Fields HL, Basbaum AI. Brainstem control of spinal pain-transmission neurons. Annu Rev Physiol 1978; 40:217-248.
52. Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969; 164:444-445.
53. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 2002; 25:319-325.
54. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991; 14:219-245.
55. Stein C, Schäfer M, Hassan AH. Peripheral opioid receptors. Ann Med 1995; 27:219-221.
56. Khasar SG, et al. Estrogen regulates adrenal medullary function producing sexual dimorphism in nociceptive threshold and beta-adrenergic receptor-mediated hyperalgesia in the rat. Eur J Neurosci 2005; 21:3379-3386.
57. Khasar SG, Green PG, Levine JD. Repeated sound stress enhances inflammatory pain in the rat. Pain 2005; 116:79-86.
58. Cooper B. Contribution of edema to the sensitization of high-threshold mechanoreceptors of the goat palatal mucosa. J Neurophysiol 1993; 70:512-521.
59. Birder LA et al. Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol Renal Physiol 2003; 285:F423-F429.
60. Yiangou Y et al. Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol 2001; 13:891-896.
61. Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 1993; 16:99-104.
62. Cho HJ et al. Expression of mRNA for brain-derived neurotrophic factor in the dorsal root ganglion following peripheral inflammation. Brain Res 1997; 749:358-362.
63. Fukuoka T et al. Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model. J Neurosci 2001; 21:4891-900.
64. Michael GJ et al. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 1997; 17:8476-8490.
65. Prescott ED, Julius D. A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 2003; 300:1284-1288.
66. Ji RR et al. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002; 36:57-68.
67. Shu X, Mendell LM. Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J Neurophysiol 2001; 86:2931-2938.
68. Tominaga M et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998; 21:531-543; [see comments].
69. Reeh PW, Petho G. Nociceptor excitation by thermal sensitization-a hypothesis. Prog Brain Res 2000; 129:39-50.
70. Catterall WA. Molecular mechanisms of gating and drug block of sodium channels. Novartis Found Symp 2002; 241:206-218; discussion 218-232.
71. Fitzgerald EM et al. Cyclic AMP-dependent phosphorylation of the tetrodotoxin-resistant voltagedependent sodium channel SNS. J Physiol (Lond) 1999; 516:433-446.
72. Isom LL. I. Cellular and molecular biology of sodium channel beta-subunits: therapeutic implications for pain? I. Cellular and molecular biology of sodium channel beta-subunits: therapeutic implications for pain?. Am J Physiol Gastrointest Liver Physiol 2000; 278:G349-G353.
73. Lai J et al. Voltage-gated sodium channels and hyperalgesia. Annu Rev Pharmacol Toxicol 2004; 44:371-397.
74. Takahashi N et al. Expression of auxiliary beta subunits of sodium channels in primary afferent neurons and the effect of nerve injury. Neuroscience 2003; 121:441-450.
75. Shah BS et al. Beta3, a novel auxiliary subunit for the voltage-gated sodium channel, is expressed preferentially in sensory neurons and is upregulated in the chronic constriction injury model of neuropathic pain. Eur J Neurosci 2000; 12:3985-3990.
76. Flake NM et al. Absence of an association between axotomy-induced changes in sodium currents and excitability in DRG neurons from the adult rat. Pain 2004; 109:471-480.
77. Cummins TR, Waxman SG. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci 1997; 17:3503-3514.
78. Patton DE et al. The adult rat brain beta 1 subunit modifies activation and inactivation gating of multiple sodium channel alpha subunits. J Biol Chem 1994; 269:17649-17655.
79. Gold MS. Sodium channels and pain therapy. Cur Op Anaesthesiol 2000; 13:565-572.
80. Rudy B. Diversity and ubiquity of K channels. Neuroscience 1988; 25:729-749.
81. Zhang XF, Gopalakrishnan M, Shieh CC. Modulation of action potential firing by iberiotoxin and NS1619 in rat dorsal root ganglion neurons. Neuroscience 2003; 122:1003-1011.
82. Cordoba-Rodriguez R et al. Calcium regulation of a slow post-spike hyperpolarization in vagal afferent neurons. Proc Natl Acad Sci USA 1999; 96:7650-7657.
83. Willis WD Jr., Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp Brain Res 1999; 124:395-421.
84. Nicol GD, Vasko MR, Evans AR. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons. J Neurophysiol 1997; 77:167-176.
85. Dang K, Bielefeldt K, Gebhart GF. Gastric ulcers reduce A-type potassium currents in rat gastric sensory ganglion neurons. Am J Physiol Gastrointest Liver Physiol 2004; 286:G573-G579.
86. Stewart T, Beyak MJ, Vanner S. Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol 2003; 552:797-807.
87. Yoshimura N, de Groat WC. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci 1999; 19:4644-4653.
88. Everill B, Kocsis JD. Nerve injury reduces total potassium conductance of two of three identified currents in adult cutaneous afferent dorsal root ganglion neurons. Soc Neurosci Abs 1997; 23:1745.
89. Gold MS, Shuster MJ, Levine JD. Role of a slow Ca2+-dependent slow afterhyperpolarization in prostaglandin E2-induced sensitization of cultured rat sensory neurons. Neurosci Lett 1996; 205: 161-164.
90. Lancaster E et al. Calcium and calcium-activated currents in vagotomized rat primary vagal afferent neurons. J Physiol 2002; 540:543-556.
91. Altier C, Zamponi GW. Targeting Ca2+ channels to treat pain: T-type versus N-type. Trends Pharmacol Sci, 2004; 25:465-470.
92. Bourinet E et al. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. Embo J 2005; 24:315-324.
93. 2+ current triggers burst firing through an afterdepolarizing potential in an adult mammalian neuron. Proc Nat Acad Sci 1989; 86:6802-6806.
94. Hogan QH et al. Painful neuropathy decreases membrane calcium current in mammalian primary afferent neurons. Pain 2000; 86:43-53.
95. Borgland SL et al. Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol 2002; 539:433-444.
96. Baccei ML, Kocsis JD. Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons. J Neurophysiol 2000; 83:2227-2238.
97. Fields RD, Lee PR, Cohen JE. Temporal integration of intracellular Ca2+ signaling networks in regulating gene expression by action potentials. Cell Calcium 2005; 37:433-442.
98. Matsuka Y et al. Concurrent release of ATP and substance P within guinea pig trigeminal ganglia in vivo. Brain Res 2001; 915:248-255.
99. Amir R, Devor, M. Chemically mediated cross-excitation in rat dorsal root ganglia. J Neurosci 1996; 16:4733-4741.
100. Amir R, Devor M. Functional cross-excitation between afferent A- and C-neurons in dorsal root ganglia. Neuroscience 2000; 95:189-195.
101. Devor M. Unexplained peculiarities of the dorsal root ganglion. Pain 1999; 6(suppl):S27-S35.
102. Byers MR. Dynamic plasticity of dental sensory nerve structure and cytochemistry. Arch Oral Biol 1994; 39(suppl):13S-21S.
103. Reinert A, Kaske A, Mense S. Inflammation-induced increase in the density of neuropeptide-immunoreactive nerve endings in rat skeletal muscle. Exp Brain Res 1998; 121:174-180.
104. Ma QP, Tian L. Cholera toxin B subunit labeling in lamina II of spinal cord dorsal horn following chronic inflammation in rats. Neurosci Lett 2002; 327:161-164.
105. Yoshimura M et al. Functional reorganization of the spinal pain pathways in developmental and pathological conditions. Novartis Found Symp 2004; 261:116-124; discussion 124-131, 149-154.
106. Ling QD et al. The pattern and distribution of calcitonin gene-related peptide (CGRP) terminals in the rat dorsal following neonatal peripheral inflammation. Neuroreport 2003; 14:1919-1921.
107. Ruda MA et al. Altered nociceptive neuronal circuits after neonatal peripheral inflammation. Science 2000; 289:628-631.
108. Belyantseva IA, Lewin GR. Stability and plasticity of primary afferent projections following nerve regeneration and central degeneration. Eur J Neurosci 1999; 11:457-468.
109. Woolf CJ. Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci 1996; 351:441-448.
110. Coull JA et al. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 2003; 424:938-942.
111. Taiwo YO, Levine JD. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience 1990; 38:752-762.
112. Gold MS et al. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci USA 1996; 93:1108-1112.
113. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002; 82:1013-1067.
114. Spelta Vet al. Extracellular ATP enhances ASIC3-like current in ischemia sensing neurons through an electrically quiet ion channel. Soc Neurosci Abs Program 859.4, 2004.
115. Wang HL et al. Heterodimerization of opioid receptor-like 1 and μ-opioid receptors impairs the potency of micro receptor agonist. J Neurochem 2005; 92:1285-1294.
116. Law PY et al. Heterodimerization of μ- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 2005; 280:11152-11164.
117. Pfeiffer M et al. Heterodimerization of substance P and μ-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 2003; 278:51630-51637.
118. Wang H, Woolf CJ. Pain TRPs. Neuron 2005; 46:9-12.
119. Tao YX et al. Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein. J Neurosci 2003; 23:6703-6712.
120. Gold MS, Flake NM. Inflammation-mediated hyperexcitability of sensory neurons. Neurosignals 2005; 14:147-157.
121. Khasar SG et al. A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron 1999; 24:253-260.
122. Taiwo YO et al. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 1989; 32:577-80.
123. Gold MS, Levine JD, Correa AM. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons In vitro [In Process Citation]. J Neurosci 1998; 18:10345-10355.
124. Chuang HH et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001; 411:957-962.
125. Huang CL, Feng S, Hilgemann DW. Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 1998; 391:803-806.
126. Ferreira SH. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs 1993; 46(suppl 1):1-9.
127. Zhang YH, Vasko MR, Nicol GD. Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na(+) current and delayed rectifier K(+) current in rat sensory neurons. J Physiol 2002; 544:385-402.
128. Zhuang ZY et al. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 2004; 24:8300-8309.
129. Misonou H et al. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci 2004; 7:711-718.
130. Zhuang ZY et al. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005; 114: 149-159.
131. Selbie LA, Hill SJ. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci 1998; 19:87-93.
132. Hucho TB, Dina OA, Levine JD. Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J Neurosci 2005; 25:6119-6126.
133. Zhou XB et al. A molecular switch for specific stimulation of the BKCa channel by cGMP and cAMP kinase. J Biol Chem 2001; 276:43239-43245.
134. Villarreal CF et al. The role of Na(V)1.8 sodium channel in the maintenance of chronic inflammatory hypernociception. Neurosci Lett 2005; 386:72-77.
135. Holthusen H. Involvement of the NO/cyclic GMP pathway in bradykinin-evoked pain from veins in humans. Pain 1997; 69:87-92.
136. Nakamura A, Fujita M, Shiomi, H. Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia. Br J Pharmacol 1996; 117:407-412.
137. Aley KO, McCarter G, Levine JD. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci 1998; 18:7008-7014.
138. Sachs D, Cunha FQ, Ferreira SH. Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc Natl Acad Sci USA 2004; 101:3680-3685.
139. Vivancos GG, Parada CA, Ferreira SH. Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues. Br J Pharmacol 2003; 138:1351-1357.
140. Levy D, Strassman AM. Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade. J Neurophysiol 2004; 92:766-772.
141. Levi-Montalcini R et al. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996; 19:514-520.
142. Bonnington JK, McNaughton PA. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 2003; 551:433-446.
143. Obata K et al. Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci 2003; 23:4117-4126.
144. Guo H, Huang LY. Alteration in the voltage dependence of NMDA receptor channels in rat dorsal horn neurones following peripheral inflammation. J Physiol 2001; 537:115-123.
145. Dolan S et al. Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia. Pain 2003; 106:501-512.
146. Guan Y et al. Inflammation-induced upregulation of AMPA receptor subunit expression in brain stem pain modulatory circuitry. Pain 2003; 104:401-413.
147. Guo W et al. Activation of spinal kainate receptors after inflammation: behavioral hyperalgesia and subunit gene expression. Eur J Pharmacol 2002; 452:309-318.
148. Ohtori S et al. Up-regulation of substance P and NMDA receptor mRNA in dorsal horn and preg-anglionic sympathetic neurons during adjuvant-induced noxious stimulation in rats. Ann Anat 2002; 184:71-76.
149. Hains BC et al. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J Neurosci 2004; 24:4832-4829.
150. Hu HJ, Glauner KS, Gereau RWt. ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. I. Modulation of A-type K+ currents. J Neurophysiol 2003; 90:1671-1679.
151. Hains BC, Saab CY, Waxman SG. Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neurons after spinal cord injury. Brain 2005.
152. Iadarola MJ et al. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 1988; 35:313-326.
153. Kohno T et al. Peripheral axonal injury results in reduced μ opioid receptor pre- and post-synaptic action in the spinal cord. Pain 2005; 117:77-87.
154. Scholz J et al. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 2005; 25:7317-7323.
155. Noguchi K et al. Axotomy induces preprotachykinin gene expression in a subpopulation of dorsal root ganglion neurons. J Neurosci Res 1994; 37:596-603.
156. Cho HJ et al. Expression of mRNAs for preprotachykinin and nerve growth factor receptors in the dorsal root-ganglion following peripheral inflammation. Brain Res 1996; 716:197-201.
157. Craft RM, Mogil JS, Aloisi AM. Sex differences in pain and analgesia: the role of gonadal hormones. Eur J Pain 2004; 8:397-411.
158. Fillingim RB, Ness TJ. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev 2000; 24:485-501.
159. Berkley KJ. Sex differences in pain. Behav Brain Sci 1997; 20:371-380.
160. LeResche L. Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors. Crit Rev Oral Biol Med 1997; 8:291-305.
161. Unruh AM. Gender variations in clinical pain experience. Pain 1996; 65:123-67.
162. Yang Y et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2004; 41:171-174.
163. Ophoff RA et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87:543-552.
164. Fillingim RB et al. The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 2005; 6:159-167.
165. Stamer UM et al. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain 2003; 105:231-238.
166. Mogil JS et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci USA 2003; 100:4867-4872.
167. Zubieta JK et al. COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science 2003; 299:1240-1243.
168. Diatchenko L et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005; 14:135-143.
169. Yoshimura N et al. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology 2001; 57:116.
170. Honore P et al. TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics. Pain 2002; 96:99-105.